Glaxo’s Weight-Loss Petition Relied On “Deeply Flawed” Survey – AHPA
This article was originally published in The Tan Sheet
Executive Summary
The American Herbal Products Association says GlaxoSmithKline used data from a flawed consumer survey when the firm asked FDA to reclassify weight loss claims as disease claims